Q301--Minimal Residual Disease (MRD)/Testing Services
ID: 36C10G25Q0045Type: Sources Sought
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFSTRATEGIC ACQUISITION CENTER FREDERICKSBURG (36C10G)FREDERICKSBURG, VA, 22408, USA

NAICS

Medical Laboratories (621511)

PSC

MEDICAL- LABORATORY TESTING (Q301)

Original Source

https://sam.gov/opp/93633cfe84eb4ef58fd02838d7f59d4e/view
Timeline
    Description

    The Department of Veterans Affairs (VA) is seeking information from potential contractors for Minimal Residual Disease (MRD) testing services as part of its National Precision Oncology Program. The objective is to identify vendors with expertise in molecular testing for colon cancer, particularly for patients diagnosed with stage II colorectal cancer post-surgery, to enhance management decisions regarding adjuvant chemotherapy. This initiative is crucial given the high incidence of colon cancer among veterans, and it involves various testing methodologies such as next-generation sequencing, flow cytometry, and polymerase chain reaction (PCR). Interested parties must respond to the request for information by February 13, 2025, providing details about their capabilities and relevant experience to Michelle Bailey at michelle.bailey@va.gov and Zachary Wilcox at zachary.wilcox@va.gov.

    Point(s) of Contact
    Michelle BaileyContract Specialist
    (202) 746-1251
    michelle.bailey@va.gov
    Files
    Title
    Posted
    36C10G25Q0045_1.docx
    The U.S. Department of Veterans Affairs (VA) is issuing a Sources Sought Notice for Minimal Residual Disease (MRD) testing services, aimed at enhancing its National Precision Oncology Program. This notice serves as a request for information (RFI) only, not a formal request for proposals, and it seeks potential contractors with expertise in molecular testing for MRD in colon cancer, particularly following surgical resection in stage II cases. The goal is to identify vendors capable of offering comprehensive laboratory services certified under the Clinical Laboratory Improvement Amendments (CLIA) to serve all U.S. states, the District of Columbia, and Puerto Rico. Various methodologies are outlined for MRD detection, including next-generation sequencing, flow cytometry, and polymerase chain reaction (PCR). Interested parties must respond by February 13, 2025, with requested information about their capabilities, prior experience, and peer-reviewed data supporting their testing methods. This initiative showcases the VA’s commitment to improving cancer management for veterans, addressing a high incidence of colon cancer diagnoses within this population.
    Lifecycle
    Title
    Type
    Q301--Minimal Residual Disease (MRD)/Testing Services
    Currently viewing
    Sources Sought
    Similar Opportunities
    6550--MRSA Molecular Microbiology
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 22, is seeking qualified vendors for MRSA Molecular Microbiology services under a Sources Sought Notice. The procurement aims to enhance clinical laboratory capabilities across various VA facilities, requiring advanced analyzers that comply with CLIA and CLSI standards, along with a continuous supply of high-quality reagents for testing infectious agents and cancer markers. This initiative is crucial for improving healthcare delivery to veterans, ensuring that the VA can meet rising medical testing demands effectively. Interested parties must submit their capabilities and relevant information by February 12, 2025, to Carlos Magana at carlos.magana@va.gov, with the solicitation number 36C26225Q0407 guiding the process.
    Q301--Natera Signatera ctDNA Analysis for RIVAL Research Study
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Regional Procurement Office - East, intends to negotiate a sole-source contract with Natera, Inc. for conducting circulating tumor DNA (ctDNA) analysis as part of the RIVAL research study, which focuses on immunotherapy in veterans with locally advanced non-small cell lung cancer (NSCLC). The contract will support the analysis of ctDNA levels in approximately 40 patients at various VA medical centers, evaluating changes pre- and post-chemotherapy combined with immunotherapy to predict patient outcomes. Natera's Signatera assay is critical for this study due to its proven sensitivity and specificity, ensuring consistent analysis across baseline and follow-up samples. Interested parties must notify the Contracting Officer, Ms. Millicent Covert, at millicent.covert@va.gov by January 31, 2025, to express their interest and capabilities, as this notice is not a solicitation for competitive proposals.
    6550--Reagents and consumables
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide reagents and consumables for the VA Greater Los Angeles Healthcare System, as outlined in the Sources Sought Notice under solicitation number 36C26225Q0399. The procurement focuses on acquiring essential products compatible with Ion Torrent technology, specifically for next-generation sequencing related to DNA and RNA testing for Myeloid and Solid Tumor classifications. This initiative is crucial for supporting advanced medical testing and diagnostics within the VA's molecular oncology reference lab, which serves a diverse patient population. Interested parties must submit their responses by February 3, 2025, at 9 AM Pacific Time, and can direct inquiries to Carlos Magana at carlos.magana@va.gov or by phone at 562-766-2253.
    ClonoSEQ Reference Testing Service
    Dept Of Defense
    The Department of Defense, specifically the U.S. Army, is seeking to procure ClonoSEQ Reference Testing Services to support the Brooke Army Medical Center's Department of Pathology in Fort Sam Houston, Texas. The contractor will be responsible for providing all necessary personnel, equipment, and supplies to perform clinical reference laboratory testing services, particularly for detecting measurable residual disease in patients with certain blood cancers. This procurement is crucial for monitoring cancer treatment and ensuring timely processing and reporting of test results, which will be securely transmitted to the Hematology/Oncology Clinic at BAMC. Interested organizations must submit capability statements by February 7, 2025, and are required to register on the System for Award Management (SAM) to be eligible for government contracts. For further inquiries, contact Colleen Rye at colleen.m.rye.civ@health.mil or Salameya Paulouskaya at salameya.paulouskaya2.civ@health.mil.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to disease diagnosis and patient health assessment. The procurement aims to establish contracts for services that comply with federal, state, and local regulations, including necessary licensing and accreditation, while ensuring that only new items are provided and that grey market goods are strictly prohibited. This opportunity is critical for enhancing the quality of healthcare services provided to veterans, with a focus on compliance with the Trade Agreements Act and other regulatory requirements. Interested vendors should contact Contract Specialist Brian O'Connell at Brian.O'connell@va.gov for further details, and they must adhere to the submission deadlines outlined in the solicitation documents.
    Q301 Reference Laboratory Testing VA Roseburg Healthcare System
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide reference laboratory testing services for the Roseburg Healthcare System in Oregon. The procurement aims to fulfill the technical and professional components of anatomical pathology and cytology specimens, including specimen processing, slide reading, and report generation, with a focus on maintaining high-quality standards and compliance with federal regulations. This opportunity is crucial for enhancing laboratory services for veterans, ensuring timely and accurate testing results. Interested vendors must respond by January 31, 2025, and provide proof of accreditation, relevant experience, and compliance with quality review requirements. For further inquiries, contact Contract Specialist Eric Lingenfelter at Eric.Lingenfelter@va.gov or by phone at 360-852-9861.
    Q301--VISN22 REFERENCE LAB TESTING SERVICES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to provide Reference Lab Testing Services under the solicitation number 36C26225Q0310 for various facilities within the Veterans Integrated Service Network 22 (VISN 22), which includes locations in California, New Mexico, Arizona, and associated outpatient clinics. The objective is to establish a single Indefinite Delivery/Indefinite Quantity (IDIQ) contract that encompasses specimen processing, testing with defined turnaround times, secure courier transportation, and compliance with cybersecurity and HIPAA protocols. This initiative is crucial for ensuring timely and efficient laboratory services for veterans' healthcare, with a contract budget ranging from $1,000 to $50 million, and implementation expected within 120 days of award. Interested parties must submit their capability statements by February 4, 2025, and can contact Contract Specialist Rebecca Gaba at Rebecca.Gaba@va.gov for further information.
    Q515--Western Colorado Health Care System Anatomic Pathology Services Base Plus Four Option Years
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide Anatomic Pathology Services for the Western Colorado Health Care System (WCHCS) at the Grand Junction VA Medical Center. The procurement encompasses a base year from October 1, 2025, to September 30, 2026, with four optional renewal years, requiring comprehensive services such as surgical specimen processing, cytological analysis, and autopsy services, all performed by a licensed consulting pathologist. This initiative aims to enhance pathology services for veterans, ensuring timely reporting of test results, adherence to quality control standards, and compliance with hazardous materials regulations. Interested parties must submit their capabilities and relevant business information to Contracting Officer Lindsey Zwaagstra at Lindsey.Zwaagstra@va.gov by 4:00 PM Mountain Time on February 14, 2024.
    Q301 Reference Laboratory Testing for Spokane VA Medical Center
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to provide reference laboratory testing services for the Spokane VA Medical Center. The procurement aims to secure comprehensive laboratory services, including preanalytic processing, analysis, reporting, and interpretation of clinical results, adhering to federal, state, and local regulations. This initiative is crucial for enhancing healthcare delivery to veterans, ensuring timely and accurate testing while maintaining compliance with standards such as CLIA and those from the College of American Pathologists. Interested parties must respond by February 14, 2025, with their qualifications and relevant documentation, as the contract is expected to span from May 1, 2025, to April 30, 2030. For further inquiries, contact Eric Lingenfelter at eric.lingenfelter@va.gov or call 360-852-9891.
    6550--Histology Reagents and Supplies
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking information from industry vendors capable of supplying Histology Reagents and Supplies as part of a Sources Sought Notice. This initiative aims to gather insights on the capabilities, qualifications, and interest of potential suppliers for future procurement, emphasizing that no proposals are currently being requested. The histology products will be utilized across various VA healthcare facilities within VISN 1, with orders placed on an as-needed basis, highlighting the critical role these supplies play in supporting healthcare services. Interested parties must submit their company information, performance capabilities, and socio-economic status to the designated contact, Manases Cabrera, at manases.cabrera@va.gov, ensuring they are registered in the System for Award Management (SAM).